TechFlow news, on November 2, according to a Hong Kong Stock Exchange announcement,港股-listed company Hua Jian Medical disclosed that since mid-August it had announced a possible major acquisition plan to acquire cryptocurrency for no more than RMB 3 billion, which was to be submitted for shareholder approval. However, the circular to shareholders has not been sent as scheduled, and there has been no progress after two and a half months. Hua Jian Medical stated that due to the need for additional time to obtain shareholder authorization, the major acquisition has been temporarily suspended. In the future, once market purchases of ETH (Ethereum) resume, disclosures will be made in accordance with the HKEX Listing Rules, particularly Chapter 14 concerning disclosable transactions. Hua Jian Medical added that its subsequent plan is to build an AI algorithm platform to improve recognition rates, and intends to integrate its distribution network, ecosystem, and RWA platform to enhance the accuracy of underlying asset valuation models and the efficiency and transparency of the securitization process.
Risk Disclosure: This website's content is not investment advice and offers no trading guidance or related services. Per regulations from the PBOC and other authorities, users must be aware of virtual currency risks. Contact us / support@techflowpost.com ICP License: 琼ICP备2022009338号
